Arrowhead Pharmaceuticals Inc. Revenue 2011–2025
Arrowhead Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arrowhead Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 73.7 M, a 86.41% decrease year-over-year.
- Arrowhead Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 908.2 M, a 14909.85% increase year-over-year.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2025 was 829.4 M, a 23258.15% increase from 2024.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2024 was 3.6 M, a 98.52% decrease from 2023.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2023 was 240.7 M, a 1.03% decrease from 2022.
- Arrowhead Pharmaceuticals Inc. annual revenue for 2022 was 243.2 M.
Arrowhead Pharmaceuticals Inc. (ARWR) — Frequently Asked Questions
Arrowhead Pharmaceuticals Inc. (ARWR) is a publicly traded US company. It has a market capitalization of $9.84B. In fiscal 2025 it reported revenue of $829M and net income of -$2M. Explore ARWR's stock price, financial statements, earnings history, margins and key ratios below.
What is Arrowhead Pharmaceuticals Inc.'s market cap?
Arrowhead Pharmaceuticals Inc. (ARWR) has a market capitalization of $9.84B.
What is the ARWR stock price?
ARWR trades at $73.60 (+4.06% on the day).
How much revenue does Arrowhead Pharmaceuticals Inc. make?
Arrowhead Pharmaceuticals Inc. reported revenue of $829M in fiscal 2025.
Is ARWR profitable?
In fiscal 2025, Arrowhead Pharmaceuticals Inc. reported net income of -$2M.